跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Proglitab MR 60
Approved
STANDARD
Proglitab MR 60
Inventia Healthcare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1656326a0e77c2a9
Company
Inventia Healthcare Limited
Type
Standard
Approval Details
Approval Id
1656326a0e77c2a9
Drug Approval Philippines Name
Proglitab MR 60
Product Name
Proglitab MR 60
Registration Number
DRP-14930
Brand Name
Proglitab MR 60
Generic Name
Gliclazide
Dosage Form
Modified-Release Tablet
Dosage Strength
60mg
Manufacturer
Inventia Healthcare Limited
Importer
Healol Pharma Corporation.
Distributor
Healol Pharma Corporation.
Company Detail Path
/organization/inventia-healthcare-limited
Issuance Date
27 February 2024
Expiry Date
27 February 2029
Pharmacologic Category
Blood Glucose Lowering Drug (Sulfonylurea)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1656326a0e77c2a9
Type
Standard
Back to Philippines FDA Approvals
Proglitab MR 60 - Philippines FDA Drug Approval Details